Variant report
Variant | esv3389160 |
---|---|
Chromosome Location | chr2:186623457-186625405 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528305230 | chr2:186623501-186623502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs78190257 | chr2:186623525-186623526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35896398 | chr2:186623526-186623527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568130214 | chr2:186623531-186623532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535957034 | chr2:186623542-186623543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550616359 | chr2:186623562-186623563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142215262 | chr2:186623593-186623594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539429823 | chr2:186623601-186623602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2216496 | chr2:186623620-186623621 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs573501253 | chr2:186623635-186623636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534191505 | chr2:186623675-186623676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555935765 | chr2:186623729-186623730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574102950 | chr2:186623791-186623792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558038046 | chr2:186623809-186623810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541993010 | chr2:186623813-186623814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186057766 | chr2:186623857-186623858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575346316 | chr2:186623887-186623888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111535156 | chr2:186624006-186624007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146397707 | chr2:186624137-186624138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112174448 | chr2:186624141-186624142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201843432 | chr2:186624144-186624145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563301050 | chr2:186624216-186624217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs59153366 | chr2:186624224-186624225 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs13036018 | chr2:186624276-186624277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535239841 | chr2:186624277-186624278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201958996 | chr2:186624328-186624329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201721010 | chr2:186624333-186624334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376587227 | chr2:186624336-186624337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368969691 | chr2:186624337-186624338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528404919 | chr2:186624357-186624358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs35750344 | chr2:186624368-186624369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112032214 | chr2:186624377-186624378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552300188 | chr2:186624432-186624433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73980269 | chr2:186624514-186624515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368941824 | chr2:186624527-186624528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189702191 | chr2:186624528-186624529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568986091 | chr2:186624532-186624533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539517645 | chr2:186624598-186624599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551375145 | chr2:186624654-186624655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182698010 | chr2:186624672-186624673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534509375 | chr2:186624728-186624729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199805382 | chr2:186624738-186624739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs55704275 | chr2:186624739-186624740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574506244 | chr2:186624748-186624749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555782210 | chr2:186624790-186624791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574215445 | chr2:186624814-186624815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10931194 | chr2:186624828-186624829 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs144398957 | chr2:186624845-186624846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146634975 | chr2:186624916-186624917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541889687 | chr2:186624921-186624922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186606800-186632000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr2:186613600-186635000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
3 | chr2:186622400-186625800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |